Share on StockTwits

Stock analysts at Leerink Swann upped their target price on shares of Cardinal Health (NYSE:CAH) from $78.00 to $84.00 in a report issued on Tuesday. The firm currently has an “outperform” rating on the stock. Leerink Swann’s price objective points to a potential upside of 18.86% from the stock’s previous close.

In other Cardinal Health news, CAO Stuart G. Laws sold 21,266 shares of the stock in a transaction dated Thursday, July 24th. The shares were sold at an average price of $72.50, for a total value of $1,541,785.00. The sale was disclosed in a filing with the SEC, which is available at this link.

Other equities research analysts have also recently issued reports about the stock. Analysts at Mizuho reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday. Separately, analysts at ISI Group raised their price target on shares of Cardinal Health from $77.00 to $78.50 in a research note on Monday. They now have a “buy” rating on the stock. Finally, analysts at Robert W. Baird raised their price target on shares of Cardinal Health from $80.00 to $82.00 in a research note on Wednesday, July 9th. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Cardinal Health currently has a consensus rating of “Buy” and an average target price of $78.03.

Cardinal Health (NYSE:CAH) traded up 0.55% during mid-day trading on Tuesday, hitting $70.67. The stock had a trading volume of 2,437,333 shares. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $74.40. The stock has a 50-day moving average of $70.38 and a 200-day moving average of $69.30. The company has a market cap of $24.042 billion and a P/E ratio of 70.28. Cardinal Health also saw unusually large options trading on Tuesday. Investors bought 1,849 call options on the stock. This represents an increase of approximately 214% compared to the average volume of 588 call options.

Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. Analysts expect that Cardinal Health will post $4.25 EPS for the current fiscal year.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.